In particular, while 18F-AV-1451 strongly bound to Alzheimer’s disease-related tau pathology, non-specific binding of the same tracer can be found in patients with PSP and control subjects (Marquiè et al., 2015). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.